MXPA02003174A - Combinacion novedosa de loteprednol y antihistaminicos. - Google Patents
Combinacion novedosa de loteprednol y antihistaminicos.Info
- Publication number
- MXPA02003174A MXPA02003174A MXPA02003174A MXPA02003174A MXPA02003174A MX PA02003174 A MXPA02003174 A MX PA02003174A MX PA02003174 A MXPA02003174 A MX PA02003174A MX PA02003174 A MXPA02003174 A MX PA02003174A MX PA02003174 A MXPA02003174 A MX PA02003174A
- Authority
- MX
- Mexico
- Prior art keywords
- loteprednol
- antihistamines
- novel combination
- novel
- combination
- Prior art date
Links
- 229940125715 antihistaminic agent Drugs 0.000 title 1
- 239000000739 antihistaminic agent Substances 0.000 title 1
- YPZVAYHNBBHPTO-MXRBDKCISA-N loteprednol Chemical compound O=C1C=C[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)OCCl)[C@@H]4[C@@H]3CCC2=C1 YPZVAYHNBBHPTO-MXRBDKCISA-N 0.000 title 1
- 229960001798 loteprednol Drugs 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/14—Decongestants or antiallergics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pulmonology (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Ophthalmology & Optometry (AREA)
- Otolaryngology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19947234A DE19947234A1 (de) | 1999-09-30 | 1999-09-30 | Neue Kombination von Loteprednol und Antihistaminika |
| PCT/EP2000/009391 WO2001022955A2 (de) | 1999-09-30 | 2000-09-26 | Neue kombination von loteprednol und antihistaminika |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MXPA02003174A true MXPA02003174A (es) | 2003-08-20 |
Family
ID=7924100
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MXPA02003174A MXPA02003174A (es) | 1999-09-30 | 2000-09-26 | Combinacion novedosa de loteprednol y antihistaminicos. |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US7022687B1 (es) |
| EP (1) | EP1216046B1 (es) |
| JP (2) | JP5524438B2 (es) |
| AR (1) | AR025923A1 (es) |
| AT (1) | ATE241988T1 (es) |
| AU (1) | AU7907300A (es) |
| BR (1) | BR0014312B1 (es) |
| CA (1) | CA2387398C (es) |
| CZ (1) | CZ295090B6 (es) |
| DE (2) | DE19947234A1 (es) |
| DK (1) | DK1216046T3 (es) |
| EE (1) | EE04997B1 (es) |
| ES (1) | ES2199868T3 (es) |
| HU (1) | HU229606B1 (es) |
| MX (1) | MXPA02003174A (es) |
| PL (1) | PL196843B1 (es) |
| PT (1) | PT1216046E (es) |
| TW (1) | TWI224968B (es) |
| WO (1) | WO2001022955A2 (es) |
Families Citing this family (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2002366567B2 (en) * | 2001-12-05 | 2006-11-16 | Alcon, Inc. | Use of an H1 antagonist and a safe steroid to treat rhinitis |
| GB2389530B (en) | 2002-06-14 | 2007-01-10 | Cipla Ltd | Pharmaceutical compositions |
| US20090035260A1 (en) * | 2002-07-29 | 2009-02-05 | Therapicon Srl | Enhanced nasal composition of active peptide |
| UA82323C2 (uk) * | 2002-08-09 | 2008-04-10 | Меда Фарма Гмбх & Ко. Кг | Нова комбінація глюкокортикоїду та pde-інгібітору для лікування респіраторних захворювань, алергічних захворювань, астми та хронічних обструктивних легеневих захворювань |
| DE60333205D1 (de) | 2002-08-30 | 2010-08-12 | Nycomed Gmbh | Histaminika zur behandlung von allergischer rhinitis |
| BR0316203A (pt) * | 2002-11-12 | 2005-10-04 | Alcon Inc | Uso de um agente antialérgico e um esteróide para tratar rinite alérgica |
| ES2312844T3 (es) | 2002-12-12 | 2009-03-01 | Nycomed Gmbh | Medicamento de combinacion de r, r-formoterol y ciclesonida. |
| AU2004271744B2 (en) | 2003-09-16 | 2010-07-29 | Covis Pharma B.V. | Use of ciclesonide for the treatment of respiratory diseases |
| US20060263350A1 (en) * | 2003-09-26 | 2006-11-23 | Fairfield Clinical Trials Llc | Combination antihistamine medication |
| ITMI20040235A1 (it) * | 2004-02-13 | 2004-05-13 | Therapicon Srl | Preparazione farmaceutica per il cavo orale |
| ATE441419T1 (de) * | 2004-03-25 | 2009-09-15 | Bausch & Lomb | Verwendung von loteprednoletabonat zur behanldung von trockenen augen |
| US8758816B2 (en) | 2004-11-24 | 2014-06-24 | Meda Pharmaceuticals Inc. | Compositions comprising azelastine and methods of use thereof |
| DK2377557T3 (en) | 2004-11-24 | 2017-02-06 | Meda Pharmaceuticals Inc | Compositions comprising azelastine and methods for its use |
| US20070020330A1 (en) * | 2004-11-24 | 2007-01-25 | Medpointe Healthcare Inc. | Compositions comprising azelastine and methods of use thereof |
| EP2736491B1 (en) * | 2011-01-04 | 2017-04-05 | Bausch & Lomb Incorporated | Bepotastine compositions |
| AU2013266067B2 (en) * | 2012-05-25 | 2016-10-06 | Xlear, Inc. | Xylitol-based anti-mucosal compositions and related methods and compositions |
| US11690849B2 (en) | 2019-04-12 | 2023-07-04 | LA PharmaTech Inc. | Method of treating dementia |
| US10639314B1 (en) | 2019-04-30 | 2020-05-05 | LA PharmaTech Inc. | Method of treating Alzheimer's disease |
| US11938139B2 (en) | 2019-04-12 | 2024-03-26 | LA PharmaTech Inc. | Pharmaceutical compositions and methods for anxiety, depression and other psychiatric disorders |
| US11744833B2 (en) | 2019-04-12 | 2023-09-05 | LA PharmaTech Inc. | Pharmaceutical compositions and methods for treatment of insomnia |
| US11389458B2 (en) | 2019-04-12 | 2022-07-19 | LA PharmaTech Inc. | Pharmaceutical compositions and methods for treating parkinson's and huntington's disease |
| US10898493B2 (en) | 2019-04-12 | 2021-01-26 | LA PharmaTech Inc. | Pharmaceutical compositions and methods for psychiatric symptoms of patients with Alzheimer's disease |
| US10966989B2 (en) | 2019-04-12 | 2021-04-06 | LA PharmaTech Inc. | Pharmaceutical compositions and methods for treating mental, behavioral, cognitive disorders |
| US11318144B2 (en) | 2019-04-12 | 2022-05-03 | LA PharmaTech Inc. | Compositions and methods for treating Alzheimer's disease and Parkinson's disease |
| MX2022015965A (es) * | 2020-06-15 | 2023-03-14 | Alkem Laboratories Ltd | Combinacion de alcaftadina y un corticoesteroide. |
| US11351179B1 (en) | 2021-08-05 | 2022-06-07 | LA PharmaTech Inc. | Pharmaceutical compositions and methods for treatment of psychiatric disorders |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4996335A (en) | 1980-07-10 | 1991-02-26 | Nicholas S. Bodor | Soft steroids having anti-inflammatory activity |
| US4710495A (en) | 1980-07-10 | 1987-12-01 | Otsuka Pharmaceutical Co., Ltd. | Soft steroids having anti-inflammatory activity |
| EP0709099A3 (en) * | 1994-09-28 | 1996-07-24 | Senju Pharma Co | Aqueous suspension for nasal administration containing cyclodextrin |
| AU6392496A (en) * | 1995-06-29 | 1997-01-30 | Mcneil-Ppc, Inc. | The combination of topical nasal antihistamines and topical nasal steroids |
| BR9709650A (pt) * | 1996-06-04 | 1999-08-10 | Procter & Gamble | Aerosol nasal contendo um esteróide intransal e um anti-histamínico |
| JP4453987B2 (ja) * | 1997-01-16 | 2010-04-21 | 千寿製薬株式会社 | 点鼻用水性懸濁液 |
-
1999
- 1999-09-30 DE DE19947234A patent/DE19947234A1/de not_active Withdrawn
-
2000
- 2000-09-26 PL PL353486A patent/PL196843B1/pl unknown
- 2000-09-26 MX MXPA02003174A patent/MXPA02003174A/es active IP Right Grant
- 2000-09-26 EE EEP200200146A patent/EE04997B1/xx not_active IP Right Cessation
- 2000-09-26 PT PT00969303T patent/PT1216046E/pt unknown
- 2000-09-26 DK DK00969303T patent/DK1216046T3/da active
- 2000-09-26 DE DE50002478T patent/DE50002478D1/de not_active Expired - Lifetime
- 2000-09-26 HU HU0202862A patent/HU229606B1/hu not_active IP Right Cessation
- 2000-09-26 TW TW089119859A patent/TWI224968B/zh not_active IP Right Cessation
- 2000-09-26 WO PCT/EP2000/009391 patent/WO2001022955A2/de not_active Ceased
- 2000-09-26 ES ES00969303T patent/ES2199868T3/es not_active Expired - Lifetime
- 2000-09-26 AU AU79073/00A patent/AU7907300A/en not_active Abandoned
- 2000-09-26 JP JP2001526167A patent/JP5524438B2/ja not_active Expired - Fee Related
- 2000-09-26 CA CA002387398A patent/CA2387398C/en not_active Expired - Fee Related
- 2000-09-26 BR BRPI0014312-0A patent/BR0014312B1/pt not_active IP Right Cessation
- 2000-09-26 CZ CZ20021014A patent/CZ295090B6/cs not_active IP Right Cessation
- 2000-09-26 US US10/089,436 patent/US7022687B1/en not_active Expired - Fee Related
- 2000-09-26 EP EP00969303A patent/EP1216046B1/de not_active Expired - Lifetime
- 2000-09-26 AT AT00969303T patent/ATE241988T1/de active
- 2000-09-29 AR ARP000105166A patent/AR025923A1/es not_active Application Discontinuation
-
2011
- 2011-09-12 JP JP2011198367A patent/JP2012001558A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| EP1216046A2 (de) | 2002-06-26 |
| EP1216046B1 (de) | 2003-06-04 |
| CZ20021014A3 (cs) | 2002-06-12 |
| JP2003510275A (ja) | 2003-03-18 |
| AR025923A1 (es) | 2002-12-18 |
| HUP0202862A2 (hu) | 2003-01-28 |
| WO2001022955A2 (de) | 2001-04-05 |
| DK1216046T3 (da) | 2003-09-29 |
| PT1216046E (pt) | 2003-10-31 |
| ES2199868T3 (es) | 2004-03-01 |
| CA2387398C (en) | 2009-05-12 |
| ATE241988T1 (de) | 2003-06-15 |
| WO2001022955A3 (de) | 2001-05-17 |
| DE19947234A1 (de) | 2001-04-05 |
| PL353486A1 (en) | 2003-11-17 |
| PL196843B1 (pl) | 2008-02-29 |
| US7022687B1 (en) | 2006-04-04 |
| EE04997B1 (et) | 2008-04-15 |
| JP2012001558A (ja) | 2012-01-05 |
| HU229606B1 (en) | 2014-02-28 |
| CZ295090B6 (cs) | 2005-05-18 |
| TWI224968B (en) | 2004-12-11 |
| BR0014312A (pt) | 2002-05-21 |
| EE200200146A (et) | 2003-04-15 |
| HUP0202862A3 (en) | 2003-10-28 |
| AU7907300A (en) | 2001-04-30 |
| DE50002478D1 (de) | 2003-07-10 |
| CA2387398A1 (en) | 2002-03-28 |
| JP5524438B2 (ja) | 2014-06-18 |
| BR0014312B1 (pt) | 2012-09-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MXPA02003174A (es) | Combinacion novedosa de loteprednol y antihistaminicos. | |
| EG23122A (en) | Pyrrolcarboxamides and pyrrolcarbothioamides | |
| HRP20060251B1 (hr) | Supstituirani oksazolidinoni i njihova uporaba | |
| EP1283702A4 (en) | MEDICAL ASSOCIATION ARRANGEMENT AND METHOD OF THE APPLICATION | |
| AU3620600A (en) | Skin-marking devices and their use | |
| AU9667901A (en) | Mycoattractants and mycopesticides | |
| AU2002245629A1 (en) | Stabilized therapeutic and imaging agents | |
| GB9919764D0 (en) | Thyristors and their manufacture | |
| AU715620C (en) | Therapeutic methods and uses | |
| HUP0203896A3 (en) | Substituted 8-arylquinoline phosphodiesterase-4-inhibitors and use thereof | |
| AU2002252976A1 (en) | Hydrazones and their therapeutic use | |
| HUP0201105A3 (en) | Pesticidal solvates of pymetrozine, preparation and use thereof | |
| AU2841801A (en) | Triazolotriazinones and the use thereof | |
| IL146465A0 (en) | Substituted 3-pyridyl-4-arylpyrroles and related therapeutic and prophylactic methods | |
| PL353487A1 (en) | Novel combination of loteprednol and beta2 | |
| AU2529799A (en) | Benzofuran-4-carboxamides and their therapeutic use | |
| AU2669201A (en) | Taccalonolides and their use | |
| HUP0203678A3 (en) | Nitro-sulfobenzamide-derivatives, preparation and use thereof | |
| GB9906330D0 (en) | Integrated tail-lift and ramp | |
| ZA200109120B (en) | Use of Arylalkanoylpyridazines. | |
| GB9929581D0 (en) | Comjpositions and their use | |
| HUP0201800A2 (en) | Novel calpains and their use | |
| ZA991021B (en) | Benzofuran-4-carboxamides and their therapeutic use. | |
| GB9916675D0 (en) | Enigma-sip and enigma-cell | |
| IL149638A0 (en) | S-allylmercaptoglutathione and uses thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant or registration | ||
| HC | Change of company name or juridical status |